Why Canopy Growth (TSX:WEED) Is Only Worth $14.34 Per Share

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) has increased 1,672% since its IPO, but now is the time to sell.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you’d told someone two decades ago that recreational marijuana use would be legalized in Canada, they would not have believed you and would likely  have asked if you were high.

As of October 17, 2018, the Government of Canada legalized marijuana for recreational purposes.

Fast forward nine months, and Canada’s largest marijuana company Canopy Growth (TSX:WEED)(NYSE:CGC) has a market capitalization of almost $16 billion.

Canopy Growth’s stock price has increased 1,672% since its IPO, but this trend is unlikely to continue, and here is why.

Declining net incomes

The company raised $526 million through a capital stock issuance in 2018, which was followed by a $5.2 billion capital stock issuance the following year. In 2019, the company also raised $600 million through the issuance of debt for a total of $5.8 billion raised.

Despite this, the company’s losses have continued to grow with net losses of $70 million in FY 2018 and $685 million in FY 2019.

Although it is common for companies in the growth stage to raise significant amounts of capital through stock and debt issuance, it is rare that net losses increase exponentially, despite raising capital.

As investors, we are concerned about the bottom line, and Canopy Growth has proven it has not been able to deliver.

Grossly overvalued

A recent report by the Financial Post pegs the marijuana industry’s valuation at a mere $5 billion by 2021.

Assuming that Canopy Growth dominates the marijuana market and goes on an acquisition frenzy, whereby it purchases all Canadian marijuana companies to capture 100% of the market, its market capitalization would still be overvalued by a factor of approximately three.

Simply put, Canopy Growth’s stock price should be trading at $14.34, and the increasing amount of short-sellers supports this bearish sentiment.

The marijuana industry is operating in a bubble. This means that once the hype is gone, marijuana stocks will see a major correction, which could translate into massive losses for investors.

Bottom line

Similar to the dot com bubble in the early 2000s and the pre-2008 mortgage-backed securities market, all bubbles must eventually pop.

The downside to being the largest player in a bubble is that when trouble hits, it will take the greatest hit.

Let us not forget Lehman Brother’s, which once epitomized banking in the United States. After the 2008 recession, the company was so entrenched in mortgage-backed securities that the government refused to bail it out.

Canopy Growth has raised billions of dollars through stock and debt issuances, yet its net losses continue to increase exponentially.

Further to this, the company has a market capitalization of $16 billion, which is three times greater than the total marijuana market value of $5 billion by 2021.

The numbers do not add up for Canopy Growth, and I would caution you stay away or get out.

Should you invest $1,000 in Canopy Growth right now?

Before you buy stock in Canopy Growth, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Canopy Growth wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $21,345.77!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 24 percentage points since 2013*.

See the Top Stocks * Returns as of 4/21/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Chen Liu has no position in the companies mentioned.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Stocks for Beginners

Buy the Dip Before It’s Too Late: This Canadian Stock Won’t Stay Cheap Forever

Investors might think that cannabis stocks are out, but this one could be the top Canadian stock to consider.

Read more »

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »